Improving the Lives of Patients with ADHD

Just as an individual changes as they transition from childhood through adulthood, so does the presentation of attention-deficit hyperactivity disorder (ADHD). During this half-day program, progression of ADHD symptoms, as well as the latest updates to treatment strategies for ADHD, will be explored by two of the leading authorities on ADHD.

All sessions will be held in Pacific Time (PT).

Saturday, August 24, 2024

7:00 am - 8:00 am

Attention Please! Guidelines for Diagnosing and Treating Adult ADHD in the Context of Comorbidities

David W. Goodman, MD, FAPA

Although the onset of attention-deficit hyperactivity disorder (ADHD) occurs during childhood, it often persists into adulthood and can tremendously impact functioning and quality of life for both patients and their loved ones. In this presentation, Dr. David Goodman will discuss ways in which the presentation of ADHD may change as children progress into adulthood. Strategies for making a differential diagnosis and treating adult ADHD in the context of common comorbidities will also be delineated.

8:00 am - 9:00 am

Industry Session


9:00 am – 9:05 am


9:05 am – 9:35 am

Poster Session


9:35 am - 10:35 am

What’s New? An Update on Treatment Options for ADHD Across the Lifespan

Timothy E. Wilens, MD

Over the past few years, there have been several updates in the approvals, indications, and available formulations of treatments for attention-deficit hyperactivity disorder (ADHD). Here, Dr. Timothy Wilens will explore the stimulant, non-stimulant, and nonpharmacological treatment options for ADHD throughout the lifespan as well as providing insight on strategies to optimize treatment to best suit the needs of the individual patient.

10:35 am - 11:00 am

The content of all non-CME/CE events (Industry Symposia, Disease State Sessions, and Poster Sessions) and the views expressed therein are those of the presenting entity and not of NEI. These events are not part of the scientific program and do not provide CME/CE credit. By opening a non-CME/CE event, the attendee opts in to receive follow-up information from the commercial sponsor.

Program Faculty

David W. Goodman, MD, FAPA

Assistant Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD

Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, State University of New York Upstate, Syracuse, NY

David W. Goodman, MD, FAPA, is an assistant professor in the department of psychiatry and behavioral sciences at Johns Hopkins School of Medicine in Baltimore, and the director and founder of the Adult Attention Deficit Disorder Center of Maryland in Baltimore, MD. His interests include adult ADHD, associated mood/anxiety/substance use disorders, and complex psychopharmacology.

read more +

Timothy E. Wilens, MD

Chief, Division of Child and Adolescent Psychiatry; Co-Director, Center for Addiction Medicine; Massachusetts General Hospital for Children, Boston, MA  

Professor, Department of Psychiatry, Harvard Medical School, Boston, MA

Dr. Timothy E. Wilens is chief of the Division of Child and Adolescent Psychiatry at Massachusetts General Hospital (MGH), (co) director of the Center for Addiction Medicine at MGH, and the MGH Trustees Chair in Addiction Medicine. He is a professor of Psychiatry at Harvard Medical School.  

Dr. Wilens earned his BS in literature, science, and arts at the University of Michigan Honors College and his MD at the University of Michigan Medical School in Ann Arbor. His residency in child, adolescent and adult psychiatry was completed at Massachusetts General Hospital under the auspices of Harvard Medical School.  He is triple board certified in child/adolescent, adult, and addiction psychiatry.  

Dr. Wilens’ research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders, embedded health care models, and the pharmacotherapy of ADHD across the lifespan. He has published more than 300 peer-reviewed articles, concerning these and related topics, in prestigious journals such as JAMA, American Journal of Psychiatry, Archives of General Psychiatry, and Pediatrics. Dr. Wilens has also coedited/published more than 80 book chapters, 4 books, and 300 abstracts and presentations for national and international scientific meetings.  

Dr. Wilens is a distinguished fellow of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry (AACAP), serves as the chair of new research and psychopharmacology committees for AACAP, is on the editorial boards or is a scientific reviewer for more than 35 journals, and is active in several other local and national professional societies.  

Dr. Wilens is named consistently among “The Best of Boston” in Child/Adult Psychiatry and “The Best Doctors in America.”

read more +